Table 1 Neutralization capacity of the pooled antisera against EV71 viruses.
Pooled antisera | 100 μg/dose | 10 μg/dose | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
pSVA | 02203 | 03149 | 52-3 | 02969 | pSVA | 02203 | 03149 | 52-3 | 02969 | |
(B3) | (B4) | (C2) | (C4) | (C5) | (B3) | (B4) | (C2) | (C4) | (C5) | |
Anti-HBc-E1/2 | 1:32 | 1:64 | 1:128 | 1:256 | 1:128 | 1:32 | 1:32 | 1:16 | 1:32 | 1:16 |
Anti-HBc-E1 | 1:8 | 1:16 | 1:64 | 1:64 | 1:128 | 1:8 | 1:16 | 1:32 | 1:16 | 1:8 |
Anti-HBc-E2 | 1:16 | 1:16 | 1:32 | 1:128 | 1:64 | 1:8 | 1:8 | 1:16 | 1:8 | 1:8 |
Anti-HBc(aa1-149) | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 |
adjuvant | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 | <1:8 |